HHS_ASPE

@HHS_ASPE

Office of the Assistant Secretary for Planning and Evaluation at the US Department of Health and Human Services

Washington, DC

HHS_ASPE
@HHS_ASPE
Oct 21
💡NEW BRIEF: Restoring vibrancy in kidney care, thereby improving patient outcomes and reducing costs, requires thoughtfully reviewing and modernizing the regulatory framework governing kidney care to better encourage competition, innovation, and patient-centered care.
Ge Bai and 8 others
1
HHS_ASPE
@HHS_ASPE
Oct 21
💡NEW BRIEF: The 2025 Working Families Tax Cut legislation may reduce ESI premiums by up to 2.2-2.5 percent by 2032.
Ge Bai and 8 others
1
HHS_ASPE
@HHS_ASPE
Oct 14
Join us at the next HHS Health Economics and Policy Forum!
Ge Bai and 8 others
1
HHS_ASPE
@HHS_ASPE
Oct 9
ASPE’s Chief Economist and Chief Regulatory Officer Casey Mulligan explains how @CMSGov plans to fix a major flaw in the 340B drug discount program. See more ⬇️
How CMS plans to fix a major flaw in the 340B drug discount program
From statnews.com
2
HHS_ASPE
@HHS_ASPE
Oct 9
💡NEW BRIEF: @CMSGov reform to the 340B Drug Pricing Program will improve drug affordability and decrease financial incentives for consolidation.
2